Lv41
756 积分 2024-12-16 加入
A first-in-class pulsatile FXR agonist for bile-acid-related liver diseases
1小时前
待确认
Phase 1 Study of Topical Administration of Novel Phosphodiesterase‐4 Inhibitor PF‐07038124 in Japanese Healthy Participants
5个月前
已关闭
Teclistamab, a B-cell maturation antigen × CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MajesTEC-1): a multicentre, open-label, single-arm, phase 1 study
11个月前
已关闭
Teclistamab, a B-cell maturation antigen × CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MajesTEC-1): a multicentre, open-label, single-arm, phase 1 study
11个月前
已完结
皖公网安备34019202002308
